11-09-2017 06:10 AM CET - Health & Medicine
Print

Johnson & Johnson Services Inc. Dominated North America Drug Delivery Market Followed by Novartis AG, GlaxoSmithKline plc., Becton Dickinson and Company

Press release from: Data Bridge Market Research
North America Drug Delivery Market is Growing with the Highest CAGR of 6.4%
North America Drug Delivery Market is Growing with the Highest CAGR of 6.4%


databridgemarketresearch.com as published new report on “North America Drug Delivery Market” Report 2017-2024 spread across 254 Pages, profiling 11 companies and supports with tables and figures, Also Offering 10% of discount on it.

North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024 from USD 501.37 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024.

North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024 from USD 501.37 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024.The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Free Sample Report of North America Drug Delivery Market Visit @ databridgemarketresearch.com/request-a-sample/?dbmr=north...

The North America Drug Delivery Market are rising prevalence of chronic disease such as diabetes, growth of biologics, new product launches, drug innovation, technological advancements andgrowth in the development of biologics. On the other hand, factors such as side effects and injuries, infections, safety measures regarding the use of devices used for the administration of drug, patent expiry, product recall and patent cliff hampers the growth of the market.

Market Segmentation:

The drug delivery market is segmented on the basis of
• Route Of Administration
• End Users
• Region
On The Basis Of Route Of Administration the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal.
On The Basis Of Distribution Channel the North America drug delivery market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy. In 2017, the direct tenders segment is expected to dominate the market.

Inquire for further detailed with TOC visit @ databridgemarketresearch.com/reports/north-america-drug-d...

On The Basis Of End Users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others. The hospitals segment dominates the North America drug delivery market with more than 40.0% market share.

The market is also segmented on the basis of end users into hospitals, research laboratories and others.

Based on North America, the market is segmented into three geographical regions:
• U.S.
• Canada
• Mexico
The major factors driving the market for North America drug delivery market are rising prevalence of chronic disease such as diabetes, growth of biologics, new product launches, drug innovation, technological advancements and growth in the development of biologics.

Some of the major players operating in this market are
• Johnson & Johnson Services, Inc.
• Novartis AG
• Pfizer, Inc.
• Merck & Co.Inc.
• Antares Pharma
• 3M
• Becton Dickinson and Company
• Cima Labs Inc.
• Valeant Pharmaceuticals International, Inc.
• Catalent, Inc.

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. North America Drug Delivery Devices Market, By Product Type
7. North America Drug Delivery Devices Market, By End User
8. North America Drug Delivery Devices Market, By Distribution Channel
9. Drug Delivery Market, By Geography
10. North America Drug Delivery Devices Market, Company Share
11. Company Profiles

Request For TOC Visit @ databridgemarketresearch.com/toc/?dbmr=north-america-drug...

Related Report

Global Orphan Drugs Market – Industry Trends and Forecast to 2024

Global Orphan Drugs Market By Product Based (Biologics, Non-Biologiocs), By Disease Type (Oncologic, Metabolic, Hematologic & Immunologic, Infectious, Neurologic), By Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-orphan-drugs-...

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.
News-ID: 808252 • Views: 1643
More releasesMore releases

You can edit or delete your press release here: